Oncimmune
Founded 2006 · 33 employees on LinkedIn · 2 known investors
Oncimmune operates ImmunoINSIGHTS, an antibody/autoantibody biomarker discovery platform that profiles antibodies from low-volume biological samples using a library of ~9,000 human antigens and machine learning analytics. It serves clients developing precision medicine, providing biomarker discovery, bioinformatics, and multiomics data integration.
Founders & leadership
MG
Martin GouldstoneCEO
Investors · 2
Frequently asked questions
- What does Oncimmune do?
- Oncimmune operates ImmunoINSIGHTS, an antibody/autoantibody biomarker discovery platform that profiles antibodies from low-volume biological samples using a library of ~9,000 human antigens and machine learning analytics. It serves clients developing precision medicine, providing biomarker discovery, bioinformatics, and multiomics data integration.
- Who are Oncimmune's investors?
- Oncimmune's investors include Balderton Capital, Seneca Partners.